US Patent 7317000 Glucose-dependent insulins

Patent 7317000 was granted and assigned to Novo Nordisk on January, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7317000

Date of Patent

January 8, 2008

Patent Application Number

10307678

Date Filed

December 2, 2002

Patent Citations Received

‌

US Patent 11767332 Glucose-sensitive albumin-binding derivatives

Patent Primary Examiner

‌

Cecilia J. Tsang

Patent abstract

The present invention relates to insulin derivatives having a built-in glucose sensor and a polyol moiety, capable to deliver insulin from an injected depot of an insulin derivative according to the invention as a function of the glucose concentration in the surrounding tissue.